Gluconic Acid

Gluconic Acid

SCHEMBL338748

O=C(O)[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A

The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 1/20 1.00
▸ LMNA P02545 2/20 0.67
▸ USP2 O75604 1/20 0.60
▸ SLCO1B1 Q9Y6L6 1/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.55
▸ TSHR P16473 2/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ OR51E2 Q9H255 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.41
▸ PGD P52209 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gluconic Acid SCHEMBL147940 1.00 PDE4A (1.00) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Mucic Acid SCHEMBL7527588 1.00 PDE4A (1.00) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Mucic Acid SCHEMBL7538629 1.00 PDE4A (1.00) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL8465565 1.00 PDE4A (1.00) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL16609880 1.00 PDE4A (1.00) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL16609822 1.00 PDE4A (1.00) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL433662 1.00 PDE4A (1.00) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL338310 1.00 PDE4A (1.00) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL21778048 1.00 PDE4A (1.00) PDE4ALMNAUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL16609840 1.00 PDE4A (1.00) PDE4ALMNAUSP2SLCO1B1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2475 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114113560-B Blood metabolism marker for estimating Glomerular Filtration Rate (GFR) and application thereof 彭洪泉 2026-05-15 — — CN claimed
CN-121040346-B Microorganism synergistic plant planting method in heavy metal contaminated soil 中国科学院沈阳应用生态研究所 2026-05-12 — — CN claimed
US-12584924-B2 Compositions and methods for diagnosing and treating chronic kidney disease SOCIETE DES PRODUITS NESTLE S.A. (CH) 2026-03-24 — — US claimed
US-20260028524-A1 BLEND OF PHOSPHONATE ACIDS FOR SCALE PREVENTION IN HIGH ALKALINITY AND HIGH CO2 ENVIRONMENTS HALLIBURTON ENERGY SERVICES, INC (US) 2026-01-29 — — US claimed
WO-2025263641-A1 COMPOSITION COMPRISING GLYCOLIPID, CATIONIC POLYMER AND (POLY)HYDROXY ACID L'OREAL (FR) 2025-12-26 — — WO claimed
US-20250369124-A1 IMIDAZOLINE-SUGAR CONJUGATE COMPOSITIONS AND METHODS FOR INHIBITING CORROSION ECOLAB USA INC. (US) 2025-12-04 — — US claimed
US-20250369123-A1 ALKOXYIMIDAZOLINIUM QUATERNARY SALT COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS TO INHIBIT CORROSION ECOLAB USA INC. (US) 2025-12-04 — — US claimed
US-12460155-B2 Sugar/gluconoamide alkoxylate compositions and uses thereof ECOLAB USA INC. (US) 2025-11-04 — — US claimed
EP-4618780-A1 CONSUMABLE FOR AEROSOLISABLE FORMULATION Nicoventures Trading Limited (GB) 2025-09-24 — — EP claimed
EP-4618781-A1 CONSUMABLE FOR AEROSOLISABLE FORMULATION Nicoventures Trading Limited (GB) 2025-09-24 — — EP claimed
EP-0278447-A2 Fermentation process for producing 2-keto-L-gulonic acid Institute of Microbiology Academia Sinica (CN) 1988-08-17 — — EP claimed
EP-0276284-A1 METHOD OF THERMALLY PROCESSING FOODSTUFFS AMERICAN NATIONAL CAN COMPANY (US) 1988-08-03 — — EP claimed
EP-0273202-A2 Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. Van Scott, Eugene J., Dr. (US) 1988-07-06 — — EP claimed
US-4728455-A TRIVALENT MANGANESE COMPLEX CATALYST LEVER BROTHERS COMPANY (US) 1988-03-01 — — US claimed
WO-1988000799-A1 METHOD OF THERMALLY PROCESSING FOODSTUFFS AMERICAN NATIONAL CAN COMPANY (US) 1988-02-11 — — WO claimed
EP-0237111-A2 Detergent bleach composition, bleaching compositions and bleach activators UNILEVER N.V. (NL) 1987-09-16 — — EP claimed
EP-0080879-B1 PHARMACEUTICAL COMPOSITION CONTAINING INTERFERON IN STABLE STATE SUNSTAR KABUSHIKI KAISHA (JP) 1986-10-01 — — EP claimed
US-4421924-A FROM GULONO-1,4-LACTONE PFIZER INC. (US) 1983-12-20 — — US claimed
EP-0000243-B1 PROCESS FOR PREPARING 3,5:4,6- PROTECTED DERIVATIVES OF L- OR D- GULONIC ACID, THEIR USE IN PREPARING 2- KETO-L- OR D- GULONIC ACID OR THEIR ESTERS OR L- OR D- ASCORBIC ACID, AND CERTAIN NOVEL 2-NITRATO-GULONATE INTERMEDIATES PFIZER INC. (US) 1981-01-07 — — EP claimed
EP-0000243-A1 Process for preparing 3,5:4,6- protected derivatives of L- or D- gulonic acid, their use in preparing 2- keto-L- or D- gulonic acid or their esters or L- or D- ascorbic acid, and certain novel 2-nitrato-gulonate intermediates PFIZER INC. (US) 1979-01-10 — — EP claimed
Send feedback